<html>
<head>PUBMED IDs for FBI-1</head>
<body bgcolor='#C5F0F2'><h1>FBI-1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9973611/'>FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein.</a> February 12  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11907272/'>FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.</a> March 22  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12004059/'>POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.</a> May 11  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12393420/'>Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survival.</a> October 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12750370/'>Flexible DNA binding of the BTB/POZ-domain protein FBI-1.</a> May 17  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15917220/'>FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB.</a> May 27  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17189472/'>Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator.</a> December 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18368381/'>Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4.</a> March 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18682402/'>Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN).</a> August 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18801742/'>Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors.</a> September 20  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19244234/'>Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.</a> July 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19471103/'>Eukaryotic translation initiator protein 1A isoform, CCS-3, enhances the transcriptional repression of p21CIP1 by proto-oncogene FBI-1 (Pokemon/ZBTB7A).</a> August 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19471102/'>MiR-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf.</a> August 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21176152/'>Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers.</a> March 26  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23658227/'>The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.</a> September 21  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24382891/'>Human Kruppel-related 3 (HKR3) is a novel transcription activator of alternate reading frame (ARF) gene.</a> April 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24514149/'>The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24857950/'>FBI-1 enhances ETS-1 signaling activity and promotes proliferation of human colorectal carcinoma cells.</a> February 28  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25192290/'>EPAS-1 mediates SP-1-dependent FBI-1 expression and regulates tumor cell survival and proliferation.</a> May 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26093985/'>FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.</a> June 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27492460/'>MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.</a> August 6  2016<br></body></html>
